fitness

05

Jul'21

Presently, close to 50 companies are offering a variety of analytical testing solutions for the assessment of novel cancer biomarkers.

Over time, pharmaceutical players have demonstrated significant interest in this domain and have launched clinical research initiatives to investigate the …

Read More

05

Jul'21

Cancer biomarkers market for TMB, MSI / MMR and TILs is estimated to be worth USD 860 million in 2030, predicts {Roots Analysis}

Advances in biotechnology have enabled the identification of several novel biomarkers, which are presently being used for a variety of …

Read More

02

Jul'21

The microbial contract biomanufacturing market is estimated to be worth USD 9.3 billion in 2030, predicts {Roots Analysis}

Benefits offered by microbial biomanufacturing, such as low production costs and faster development timelines, have led many innovators to adopt …

Read More

02

Jul'21

The microbial contract biomanufacturing market is growing at a CAGR of 8.7%, claims {Roots Analysis}

The growing pipeline of biologics that can be produced in microbial systems, such as antibody fragments and plasmid-based therapies, is …

Read More

02

Jul'21

More than 200 preventive vaccines, developed by both industry and non-industry players. (Roots Analysis)

Technical advances, especially in the field of biotechnology, have led to the development of several next generation preventive vaccines, including …

Read More

02

Jul'21

The global preventive vaccines market is growing at a CAGR of 10.7%, claims (Roots Analysis)

Roots Analysis has done a detailed report on Global Preventive Vaccines Market, 2020-2030, covering key aspects of the industry and …

Read More
Copyrights © 2020 Blavida.
Skip to toolbar